Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens.

Схожі ресурси

• Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens.
  за авторством: Alexandra U. Scherrer, та інші
  Опубліковано: (2013-01-01)
• Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
  за авторством: Alexandra U Scherrer, та інші
  Опубліковано: (2012-01-01)
• Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.
  за авторством: Viktor von Wyl, та інші
  Опубліковано: (2013-01-01)
• Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
  за авторством: Teja Turk, та інші
  Опубліковано: (2017-09-01)
• High Performance Liquid Chromatographic Assay for the Determination of Protease Inhibitors (PIs) and Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in Human Plasma
  за авторством: Kantima Sangsiriwut, та інші
  Опубліковано: (2020-07-01)